PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Dicitratobismuthate→

Dicitratobismuthate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
57644-54-9
Molecular formula
K3Bi(C6H5O7)2
Molecular weight
704.47 g/mol
Drug class
Bismuth tripotassium dicitrate (colloidal bismuth subcitrate)gastrointestinal mucosal protectant
Mechanism of action
Acts through several local gastrointestinal mechanisms: forms a protective layer over ulcerated mucosa, increases mucus glycoprotein secretion, inhibits peptic activity and has activity against Helicobacter pylori. Its effects are not adequately described by a single molecular target.
Indications / reported uses
  • Treatment of gastric and duodenal ulcers
  • Part of combination regimens for Helicobacter pylori eradication, according to the current local product information and antimicrobial regimen

Sources: NCI Drug Dictionary — Bismuth subcitrate · PubMed — The mode of action of colloidal bismuth subcitrate · PubMed — Studies on the mechanism of action of colloidal bismuth subcitrate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Dicitratobismuthate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dicitratobismuthate Permitted Daily Exposure (PDE) report (the Dicitratobismuthate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dicitratobismuthate Occupational Exposure Limit (OEL) report (the Dicitratobismuthate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.